Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-024978
Filing Date
2021-05-07
Accepted
2021-05-07 06:01:11
Documents
2
Period of Report
2021-05-07

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea140444-6k_tizianalifesc.htm 6-K 15420
2 TIZIANA LIFE SCIENCES INTERVIEW TO AIR ON BLOOMBERG TELEVISION U.S. ON THE REDCH ea140444ex99-1_tizianalifesc.htm EX-99.1 8069
  Complete submission text file 0001213900-21-024978.txt   24521
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 21900065
SIC: 2834 Pharmaceutical Preparations